Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AURKA | O14965 | 2/20 | 0.38 |
| ▸ | AURKB | Q96GD4 | 2/20 | 0.38 |
| ▸ | BRD4 | O60885 | 8/20 | 0.37 |
| ▸ | BCL6 | P41182 | 1/20 | 0.37 |
| ▸ | CDK2 | P24941 | 3/20 | 0.35 |
| ▸ | CDK9 | P50750 | 2/20 | 0.35 |
| ▸ | CCNE1 | P24864 | 2/20 | 0.35 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.35 |
| ▸ | CDK1 | P06493 | 1/20 | 0.34 |
| ▸ | BTK | Q06187 | 2/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.33 |
| ▸ | CDK7 | P50613 | 1/20 | 0.33 |
| ▸ | ALK | Q9UM73 | 2/20 | 0.33 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.32 |
| ▸ | FLT3 | P36888 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1115763 | 1.00 | AURKA (0.38) | AURKAAURKBBRD4BCL6CDK2 | |
| SCHEMBL1115583 | 0.92 | CDK7 (0.36) | AURKAAURKBBRD4CDK2CDK9 | |
| SCHEMBL1115590 | 0.92 | CDK7 (0.36) | AURKAAURKBBRD4CDK2CDK9 | |
| SCHEMBL5643594 | 0.86 | BRD4 (0.48) | AURKAAURKBBRD4BCL6CDK2 | |
| SCHEMBL4981953 | 0.86 | CDK2 (0.47) | AURKAAURKBBRD4CDK2CDK9 | |
| SCHEMBL1116016 | 0.86 | SYK (0.38) | AURKAAURKBCDK2CDK9CDK1 | |
| SCHEMBL1115978 | 0.86 | SYK (0.38) | AURKAAURKBCDK2CDK9CDK1 | |
| SCHEMBL1115640 | 0.85 | AURKA (0.34) | AURKAAURKBCDK2CDK9CDK1 | |
| SCHEMBL1115643 | 0.85 | AURKA (0.34) | AURKAAURKBCDK2CDK9CDK1 | |
| SCHEMBL1115639 | 0.81 | CDK9 (0.34) | AURKAAURKBCDK2CDK9CCNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2089369-B1 | 2,4 -PYRIMIDINEDIAMINE DERIVATIVES AS INHIBITORS OF JAK KINASES FOR THE TREATMENT OF AUTOIMMUNE DISEASES | RIGEL PHARMACEUTICALS INC (US) | 2011-02-02 | — | — | EP | claimed |